Can New HER2-Positive Therapies be Used in Early Stage Breast Cancers?

patientpower has 2382 videos Subscribe Here

Description: Dr. Julie Gralow discusses who benefits from HER2-targeted therapies like KADCYLA or T-DM1 (ado-trastuzumab emtansine) and current studies underway looking at using these targeted therapies much earlier in the treatment of breast cancer. Dr. Gralow also talks about what the future holds for HER2-targeted therapies, how broadly these therapies might be used and what current drugs might be replaced?
Shared By : patientpower
Posted on : 03/13/13
Added : 5 years ago
Category : Breast Cancer